Skip to content

EFFICACY OF TENS THERAPY AS AN ADJUNCTIVE THERAPY IN THE MANAGEMENT OF ORAL NEUROPATHIC PAIN- A RANDOMISED CONTROLLED TRIAL

EFFICACY OF TRANSCUTANEOUS ELECTRIC NERVE STIMULATION AS AN ADJUNCTIVE THERAPY IN THE MANAGEMENT OF PAINFUL POSTTRAUMATIC TRIGEMINAL NEUROPATHY: A RANDOMISED CLINICAL STUDY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078561
Enrollment
50
Registered
2024-12-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G64- Other disorders of peripheral nervous system

Interventions

Intervention1: Pharmacotherapy + TENS therapy: Pharmacotherapy - Pregabalin 150 mg in 2 divided doses per day + Tryptomer 10 mg OD TENS - 30 minutes twice weekly in continuous mode at a current inten

Sponsors

AMLENDU SHEKHAR
Lead Sponsor
faculty of dental sciences
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: History of an identifiable traumatic event to the trigeminal nerve(s), with clinically evident altered sensation in the affected region positive (hyperalgesia, allodynia) and/or negative(hypaesthesia, hypalgesia) signs of trigeminal nerve dysfunction Patient with continuous pain for more than three months after extraction of teeth on the same side of the face. Pain developed within 6 months after the traumatic event. Involvement of only maxillary or mandibular branch of trigeminal nerve. Patient should not have any other systemic illness. Normal baseline blood investigations report.

Exclusion criteria

Exclusion criteria: Pain with no history of extraction/ other traumatic event of teeth. History of traumatic event on the opposite side of the face. Patients with symptoms of classical trigeminal neuralgia.Presence of central lesion as ascertained by MRI brain.

Design outcomes

Primary

MeasureTime frame
1) Pain intensity reported on visual analog scale VAS score (0- 10) - patients will be asked to mark their level of pain from O (no pain) to 10 (worst pain) on the case recording sheet. 2) Present pain intensity on the PPI scale (0-5) - patients will be asked to score their pain from 0 (no pain) to 5 (excruciating pain). 3) Short-form -McGill Pain Questionnaire 2 (SF-MPQ2) score (0- 10)- assesses the quality or type of pain that the patient was suffering from, which was scored from (0) no pain to (10) worst pain. Timepoint: Baseline, 1 month, 3 months and 6 months

Secondary

MeasureTime frame
Functional outcome score (0- 10) - patients will be asked about how their daily activities are affected by their pain. It will be recorded at subsequent sittings to determine whether treatment was resulting in any pain relief while performing daily activities. Dose reduction Timepoint: 1 month, 3 months and 6 months

Countries

India

Contacts

Public ContactDr Adit

Institute of Medical Sciences, Banaras Hindu University

adit@bhu.ac.in09451525522

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026